OvaScience Company Profile (NASDAQ:OVAS)

About OvaScience

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OVAS
  • CUSIP:
Key Metrics:
  • Previous Close: $8.40
  • 50 Day Moving Average: $6.58
  • 200 Day Moving Average: $7.18
  • 52-Week Range: $35,561,000.00 - $4.53
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.04
  • P/E Growth: 0.00
  • Market Cap: $298.71M
  • Outstanding Shares: 35,561,000
  • Beta: 4.04
  • Net Margins: -13,906.35%
  • Return on Equity: -60.10%
  • Return on Assets: -55.12%
  • Current Ratio: 13.98%
  • Quick Ratio: 13.98%
Additional Links:
Companies Related to OvaScience:

Analyst Ratings

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $11.64 (38.55% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
DateFirmActionRatingPrice TargetDetails
8/10/2016JMP SecuritiesReiterated RatingNeutralView Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetNeutral$9.00 -> $8.00View Rating Details
7/12/2016Credit Suisse Group AGReiterated RatingSellView Rating Details
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00View Rating Details
4/25/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83View Rating Details
2/17/2016HC WainwrightReiterated RatingBuy$15.00View Rating Details
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00View Rating Details
(Data available from 9/26/2014 forward)


Earnings History for OvaScience (NASDAQ:OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.78)($0.62)$0.21 million$0.19 millionViewListenView Earnings Details
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details
2/25/2016Q315($0.71)($0.76)$0.27 millionViewListenView Earnings Details
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details
8/10/2015Q215($0.64)($0.64)ViewN/AView Earnings Details
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for OvaScience (NASDAQ:OVAS)
Current Year EPS Consensus Estimate: $-2.66 EPS
Next Year EPS Consensus Estimate: $-2.76 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.81)($0.81)($0.81)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.70)($0.70)($0.70)
(Data provided by Zacks Investment Research)


Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OvaScience (NASDAQ:OVAS)
Insider Ownership Percentage: 12.59%
Institutional Ownership Percentage: 80.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for OvaScience (NASDAQ:OVAS)
News IconFeatured Stock: CYS Investments, Inc. (NYSE:CYS), Ovascience Inc. (NASDAQ:OVAS) - Newburgh Press (NASDAQ:OVAS)
newburghpress.com - September 23 at 11:24 AM
News IconOvaScience, Inc.'s (OVAS): Stock Roundup - Hot Stocks Point (NASDAQ:OVAS)
www.hotstockspoint.com - September 23 at 11:24 AM
News IconBiotech Stocks Worth a Closer Look: OvaScience (NASDAQ:OVAS), Cerus (NASDAQ:CERS) - The Voice Registrar (NASDAQ:OVAS)
voiceregistrar.com - September 23 at 11:24 AM
finance.yahoo.com logoOvaScience (OVAS) Shares March Higher, Can It Continue? (NASDAQ:OVAS)
finance.yahoo.com - September 20 at 11:54 AM
News IconStock Tracker: Earnings & Estimates for Ovascience Inc. (NASDAQ:OVAS) - Frisco Fastball (NASDAQ:OVAS)
friscofastball.com - September 19 at 6:36 PM
capitalcube.com logoETF’s with exposure to OvaScience, Inc. : September 15, 2016 (NASDAQ:OVAS)
www.capitalcube.com - September 15 at 6:44 PM
businesswire.com logoOvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire (press release) (NASDAQ:OVAS)
www.businesswire.com - September 15 at 10:09 AM
4-traders.com logoOvaScience : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:OVAS)
www.4-traders.com - September 14 at 6:47 PM
finance.yahoo.com logoOvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:OVAS)
finance.yahoo.com - September 14 at 6:47 PM
News IconStock Showing Gains in Afternoon Trading: OvaScience, Inc. (NASDAQ:OVAS) - National Daily Press (NASDAQ:OVAS)
www.nationaldailypress.com - September 8 at 6:23 PM
businesswire.com logoOvaScience Announces Executive Management Changes and ... - Business Wire (press release) (NASDAQ:OVAS)
www.businesswire.com - September 8 at 10:28 AM
reuters.com logoBRIEF-Ovascience says Christophe Couturier named CFO (NASDAQ:OVAS)
www.reuters.com - September 7 at 6:46 PM
reuters.com logoBRIEF-Ovascience names Christophe Couturier as CFO (NASDAQ:OVAS)
www.reuters.com - September 6 at 6:48 PM
finance.yahoo.com logoOvaScience Announces Executive Management Changes and Appointments to Further Drive Company’s Growth (NASDAQ:OVAS)
finance.yahoo.com - September 6 at 6:48 PM
finance.yahoo.com logo4:07 pm OvaScience CFO Jeff Young is leaving the co to pursue other opportunities; co has appointed Christophe Couturier as CFO, effective immediately (NASDAQ:OVAS)
finance.yahoo.com - September 6 at 6:48 PM
biz.yahoo.com logoOVASCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:OVAS)
biz.yahoo.com - September 6 at 6:48 PM
4-traders.com logoOvaScience : to Present at Upcoming Investor Conferences in September (NASDAQ:OVAS)
www.4-traders.com - September 1 at 9:49 AM
finance.yahoo.com logoOvaScience to Present at Upcoming Investor Conferences in September (NASDAQ:OVAS)
finance.yahoo.com - August 31 at 11:42 AM
smarteranalyst.com logoCompany Update (NASDAQ:OVAS): OvaScience Inc's AUGMENT Treatment Commercially Available in Japan Through ... - Smarter Analyst (NASDAQ:OVAS)
www.smarteranalyst.com - August 29 at 6:28 PM
4-traders.com logoOvaScience :’s AUGMENT Treatment Commercially Available in Japan Through Partnership with IVF JAPAN GROUP (NASDAQ:OVAS)
www.4-traders.com - August 29 at 11:11 AM
reuters.com logoBRIEF-Ovascience says it has finalized its commercial agreement with IVF Japan Group (NASDAQ:OVAS)
www.reuters.com - August 29 at 11:11 AM
finance.yahoo.com logoOvaScience’s AUGMENT Treatment Commercially Available in Japan Through Partnership with IVF JAPAN GROUP (NASDAQ:OVAS)
au.finance.yahoo.com - August 29 at 11:11 AM
capitalcube.com logoETF’s with exposure to OvaScience, Inc. : August 26, 2016 (NASDAQ:OVAS)
www.capitalcube.com - August 26 at 6:26 PM
News IconIn-Vitro Fertilization (IVF) Market Is Expected To Grow At A CAGR Of 11.7% From 2015 To 2022: Grand View Research, Inc. (NASDAQ:OVAS)
www.usfinancialnewstoday.com - August 26 at 9:40 AM
News IconStock Tracking Lower for the Quarter: OvaScience, Inc. (NASDAQ:OVAS) - Post News (NASDAQ:OVAS)
www.kentuckypostnews.com - August 20 at 6:20 PM
News IconIn vitro Fertilization Devices and Consumables Market Size, Size, Share, Trends, Regional Outlook and Forecast Report 2020 – Acute Market Reports (NASDAQ:OVAS)
www.usfinancialnewstoday.com - August 18 at 6:53 PM
investornewswire.com logoWill Ovascience Inc. (NASDAQ:OVAS) Hit $15 Price Target? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - August 17 at 6:58 PM
finance.yahoo.com logoEdited Transcript of OVAS earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:OVAS)
finance.yahoo.com - August 15 at 7:01 PM
capitalcube.com logoETF’s with exposure to OvaScience, Inc. : August 15, 2016 (NASDAQ:OVAS)
www.capitalcube.com - August 15 at 7:01 PM
capitalcube.com logoOvaScience, Inc. :OVAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:OVAS)
www.capitalcube.com - August 12 at 6:50 PM
finance.yahoo.com logoOVASCIENCE, INC. Financials (NASDAQ:OVAS)
finance.yahoo.com - August 12 at 6:50 PM
finance.yahoo.com logoCan The Uptrend Continue for OvaScience (OVAS)? (NASDAQ:OVAS)
finance.yahoo.com - August 11 at 9:56 AM
fortune.com logoAttention Grabbing Analyst Research Reports: OvaScience Inc ... - Review Fortune (NASDAQ:OVAS)
reviewfortune.com - August 9 at 9:55 AM
smarteranalyst.com logoJMP Securities Remains Sidelined on OvaScience Inc (OVAS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:OVAS)
www.smarteranalyst.com - August 8 at 6:57 PM
News IconOvaScience Inc. reports second-quarter earnings (OVAS) - BNB Daily - BNB Daily (blog) (NASDAQ:OVAS)
www.baseball-news-blog.com - August 6 at 6:48 PM
equities.com logoOvaScience Inc. (OVAS) Jumps 13.08% on August 05 - Equities.com (NASDAQ:OVAS)
www.equities.com - August 6 at 9:30 AM
sg.finance.yahoo.com logoOvaScience reports 2Q loss (NASDAQ:OVAS)
sg.finance.yahoo.com - August 4 at 7:08 PM
biz.yahoo.com logoOvaScience Inc Earnings Call (Q2 2016) (NASDAQ:OVAS)
biz.yahoo.com - August 4 at 9:53 AM
biz.yahoo.com logoQ2 2016 OvaScience Inc Earnings Release - After Market Close (NASDAQ:OVAS)
biz.yahoo.com - August 4 at 9:53 AM
investornewswire.com logoEarnings Surprise in Focus: Ovascience Inc. (NASDAQ:OVAS) - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - August 1 at 6:28 PM
equities.com logoOvaScience Inc. (OVAS) Drops 5.66% on July 28 - Equities.com (NASDAQ:OVAS)
www.equities.com - July 29 at 6:51 PM
finance.yahoo.com logoOvaScience to Host Second Quarter 2016 Financial Results Conference Call (NASDAQ:OVAS)
finance.yahoo.com - July 28 at 4:05 PM
investornewswire.com logoCan Shares Of Ovascience Inc. (NASDAQ:OVAS) Hit $15? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 26 at 7:00 PM
kcregister.com logoOvaScience, Inc. (NASDAQ:OVAS) decreased -0.97%: EMC Corporation (NYSE:EMC), Itau Unibanco Holding (NYSE ... - KC Register (NASDAQ:OVAS)
www.kcregister.com - July 25 at 6:53 PM
News IconOvascience Inc. (NASDAQ:OVAS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 23 at 10:37 AM
News IconEquity Roundup: Stock Performance Focus on Ovascience Inc. (NASDAQ:OVAS) - Press Telegraph (NASDAQ:OVAS)
presstelegraph.com - July 20 at 7:29 PM
News IconCould OvaScience Inc Rise Even More? The Stock Had Another Big Increase Today - Consumer Eagle (NASDAQ:OVAS)
www.consumereagle.com - July 20 at 7:29 PM
News IconHeightened Volatility Spotted on Shares of: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 19 at 6:51 PM
investornewswire.com logoIs $15 Price Target Attainable For Ovascience Inc. (NASDAQ:OVAS)? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 19 at 6:51 PM
equities.com logoOvaScience Inc. (OVAS) Jumps 5.14% on July 18 - Equities.com (NASDAQ:OVAS)
www.equities.com - July 19 at 6:51 PM


OvaScience (NASDAQ:OVAS) Chart for Monday, September, 26, 2016

Last Updated on 9/26/2016 by MarketBeat.com Staff